Trial Profile
Study to evaluate the optimal dose of remifentanil infusion(effective dose in 80% of patients) required to ensure apnoea (of 30 seconds duration) during magnetic resonance imaging of the heart under general anaesthesia in children aged 1 to 6 years.
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 09 Feb 2023
Price :
$35
*
At a glance
- Drugs Remifentanil (Primary)
- Indications Anaesthesia
- Focus Therapeutic Use
- 01 Sep 2015 New trial record